Digital therapeutics (DTx) are becoming more prominent offerings in response to an increased appetite for telehealth

How Digital Therapies Can Help Reimagine Care and Treatment Get the Full Report →

Digital therapeutics (DTx) are an emerging category of evidence-based technologies that could disrupt drug development and disease treatment. DTx products have not hit the mainstream and will need to meet a high standard of clinical validation that separates these solutions from the sea of available digital health tools and apps on the market. In The Rise of Digital Therapeutics Report, Insider Intelligence presents how DTx solutions differ from typical digital health products and the opportunity they offer, as well as an analysis of the factors that will define success for DTx companies. In full, this exclusive report:

1 Examines how the pandemic has advanced DTx 2 Discusses why payers, employers, providers, and drug developers should want to invest in DTx now 3 Explains what should happen next for DTx tools to become key components of how diseases are managed and treated Get all of these insights and more when you purchase The Rise of Digital Therapeutics report for $995. Buy the Report Today →

Interested in more Insider Intelligence research? Buy Ultimate Digital Health Reports Bundle and gain immediate access to 15+ reports covering you on the most disruptive trends in the industry. Bundle Up and Save →

Email sent to: nguyenvu1187.love5@blogger.com Manage your email preferences  |  Unsubscribe  |  Terms of Service  |  Privacy Policy © 2022 Insider Intelligence, 11 Times Square, 14th FL, New York, NY 10036